CoRegen
Pre-clinicalWe have unlocked the immune system’s ability to eradicate cancer without toxicity and we are advancing these discoveries into accessible outpatient therapies.
Founded
2018
Focus
Cell & Gene Therapy
About
We have unlocked the immune system’s ability to eradicate cancer without toxicity and we are advancing these discoveries into accessible outpatient therapies.
Funding History
1Total raised: $4M
Seed$4MUndisclosedMay 15, 2023
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile